Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients

Not Recruiting

Trial ID: NCT00568282

Purpose

The primary aim of this study is to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients.

Official Title

Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients (Old Title: Significance of CD44 and or Epithelial Specific Antigen Positive Cells in the Peripheral Blood of Lung Cancer Patients) (LUN0017)

Stanford Investigator(s)

Heather Wakelee
Heather Wakelee

Winston Chen and Phyllis Huang Professor

Joel Neal, MD, PhD
Joel Neal, MD, PhD

Associate Professor of Medicine (Oncology)

Eligibility


Inclusion Criteria:Inclusion Criteria:Inclusion Criteria (Cases):

   1. Advanced stage (IIIB with malignant effusion or IV) histologically or cytologically
   confirmed NSCLC

   2. Patients must be newly diagnosed (untreated) or have evidence of disease progression
   at the time of sample collection

   3. ability to sign informed consent

   4. at least 18 years of age

Inclusion Criteria (Controls):

   1. no known prior or active malignancy

   2. ability to sign informed consent

   3. at least 18 years of age Exclusion Criteria:1. history of any other cancer other than
   non-melanoma skin cancer within the last 5 years Exclusion Criteria:1. history of any
   other cancer other than non-melanoma skin cancer within the last 5 years

2. pregnant women

Intervention(s):

procedure: phlebotomy

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lisa Zhou
650-736-4112

New Trial Alerts